Ornithine decarboxylase inhibitor

This page covers all Ornithine decarboxylase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ornithine decarboxylase (ODC).

Targets

Ornithine decarboxylase (ODC)

Marketed (1)

• Eflornithine Topical · Khyber Teaching Hospital · Dermatology
  Eflornithine inhibits ornithine decarboxylase, reducing polyamine synthesis and slowing hair growth.

Phase 3 pipeline (1)

• Eflornithine hydrochloride cream · National Skin Centre · Dermatology
  Eflornithine inhibits ornithine decarboxylase, an enzyme required for polyamine synthesis, thereby slowing hair growth in facial hirsutism.